Articolo
What pharmacy leaders should know about MFP recovery and 340B program impact
During a recent interview, we explored how the Medicare Drug Price Negotiation Program’s Maximum Fair Price (MFP) is creating new operational complexity for covered entities.
We highlighted a growing concern for many organizations: eligible refunds may be going unrecognized, creating financial and administrative risk. Now, the conversation is evolving.
In this second discussion, Anaila Moreau, Managing Director, 340B Consulting and Optimization, Accelerate Pharmacy Solutions, speaks with Tim L’Hommedieu, Senior Vice President of Pharmacy at Plenful about what has become clearer since MFP implementation began — and why identifying a missed refund is only part of the challenge.
As 340B covered entities and health systems move from awareness to action, the operational realities of MFP are becoming harder to ignore. Pharmacy and health system teams are not only working to spot missing or inaccurate MFP refunds, but also to determine how those issues can be resolved within a complex and time-sensitive process. For many, that means balancing new administrative demands with already stretched internal resources.
In this second discussion, Anaila Moreau, Managing Director, 340B Consulting and Optimization, Accelerate Pharmacy Solutions, speaks with Tim L’Hommedieu, Senior Vice President of Pharmacy at Plenful about what has become clearer since MFP implementation began — and why identifying a missed refund is only part of the challenge.
As 340B covered entities and health systems move from awareness to action, the operational realities of MFP are becoming harder to ignore. Pharmacy and health system teams are not only working to spot missing or inaccurate MFP refunds, but also to determine how those issues can be resolved within a complex and time-sensitive process. For many, that means balancing new administrative demands with already stretched internal resources.
What’s next for MFP recovery strategy and 340B reimbursement operations?
The discussion also looks ahead to what is coming next. With program expansion on the horizon, leaders may need to think beyond today’s workflows and begin preparing for greater volume, added dispute complexity, MFP refund reconciliation and broader implications for future reimbursement operations.
Missed the first discussion? Watch it here.
For covered entities, this is no longer just a policy story. It is an operational one.
Tune in to hear Anaila Moreau, and Tim L’Hommedieu discuss how 340B covered entities and health systems are responding to MFP challenges today — and what pharmacy leaders should consider as they prepare for what is next.
Missed the first discussion? Watch it here.
For covered entities, this is no longer just a policy story. It is an operational one.
Tune in to hear Anaila Moreau, and Tim L’Hommedieu discuss how 340B covered entities and health systems are responding to MFP challenges today — and what pharmacy leaders should consider as they prepare for what is next.
Let's connect
Accelerate Pharmacy Solutions partners with health systems on 340B program optimization, compliance, and audit readiness. Our 340B consulting team can help covered entities work through the operational and reconciliation challenges MFP is introducing, from claim-level data alignment to workflow improvements and full program management.
